Beatriz Elena Adrada1, Niloofar Karbasian2, Monica Huang1, Gaiane Maia Rauch3, Piyanoot Woodtichartpreecha4, Gary Whitman1. 1. Department of Breast Imaging, MD Anderson, Houston, Texas, United States. 2. Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut. 3. Department of Breast and Abdominal Imaging, MD Anderson, Houston, Texas, United States. 4. Department of Diagnostic Radiology, The Prince of Songkla University, Hat Yai, Songkhla, Thailand.
Abstract
OBJECTIVES: The purpose of this study is to determine the biological markers more frequently associated with recurrence in the reconstructed breast, to evaluate the detection method, and to correlate recurrent breast cancers with the detection method. MATERIAL AND METHODS: An institutional review board-approved retrospective study was conducted at a single institution on 131 patients treated with mastectomy for primary breast cancer followed by breast reconstruction between 2005 and 2012. Imaging features were correlated with clinical and pathologic findings. RESULTS: Of the 131 patients who met our inclusion criteria, 40 patients presented with breast cancer recurrence. The most common histopathologic type of primary breast cancer was invasive ductal carcinoma in 82.5% (33/40) of patients. Triple-negative breast cancer was the most common biological marker with 42.1% (16/38) of cases. Clinically, 70% (28/40) of the recurrences presented as palpable abnormalities. Of nine patients who underwent mammography, a mass was seen in eight patients. Of the 35 patients who underwent ultrasound evaluation, an irregular mass was found in 48.6% (17/35) of patients. Nine patients with recurrent breast cancer underwent breast MRI, and MRI showed an irregular enhancing mass in four patients, an oval mass in four patients, and skin and trabecular thickening in one patient. About 55% of patients with recurrent breast cancer were found to have distant metastases. CONCLUSION: Patients at higher risk for locoregional recurrence may benefit from imaging surveillance in order to detect early local recurrences.
OBJECTIVES: The purpose of this study is to determine the biological markers more frequently associated with recurrence in the reconstructed breast, to evaluate the detection method, and to correlate recurrent breast cancers with the detection method. MATERIAL AND METHODS: An institutional review board-approved retrospective study was conducted at a single institution on 131 patients treated with mastectomy for primary breast cancer followed by breast reconstruction between 2005 and 2012. Imaging features were correlated with clinical and pathologic findings. RESULTS: Of the 131 patients who met our inclusion criteria, 40 patients presented with breast cancer recurrence. The most common histopathologic type of primary breast cancer was invasive ductal carcinoma in 82.5% (33/40) of patients. Triple-negative breast cancer was the most common biological marker with 42.1% (16/38) of cases. Clinically, 70% (28/40) of the recurrences presented as palpable abnormalities. Of nine patients who underwent mammography, a mass was seen in eight patients. Of the 35 patients who underwent ultrasound evaluation, an irregular mass was found in 48.6% (17/35) of patients. Nine patients with recurrent breast cancer underwent breast MRI, and MRI showed an irregular enhancing mass in four patients, an oval mass in four patients, and skin and trabecular thickening in one patient. About 55% of patients with recurrent breast cancer were found to have distant metastases. CONCLUSION: Patients at higher risk for locoregional recurrence may benefit from imaging surveillance in order to detect early local recurrences.
Authors: L Romics; B K Chew; E Weiler-Mithoff; J C Doughty; I M Brown; S Stallard; C R Wilson; E A Mallon; W D George Journal: Br J Surg Date: 2012-02-24 Impact factor: 6.939
Authors: Andrea L Pusic; Evan Matros; Neil Fine; Edward Buchel; Gayle M Gordillo; Jennifer B Hamill; Hyungjin M Kim; Ji Qi; Claudia Albornoz; Anne F Klassen; Edwin G Wilkins Journal: J Clin Oncol Date: 2017-03-27 Impact factor: 44.544
Authors: Sashank Reddy; Salih Colakoglu; Michael S Curtis; Janet H Yueh; Adeyemi Ogunleye; Adam M Tobias; Bernard T Lee Journal: Ann Plast Surg Date: 2011-05 Impact factor: 1.539
Authors: Ranjna Sharma; Loren L Rourke; Steven J Kronowitz; Julia L Oh; Anthony Lucci; Jennifer K Litton; Geoffrey L Robb; Gildy V Babiera; Elizabeth A Mittendorf; Kelly K Hunt; Henry M Kuerer Journal: Plast Reconstr Surg Date: 2011-05 Impact factor: 4.730
Authors: Beatriz E Adrada; Gary J Whitman; Melissa A Crosby; Selin Carkaci; Mark J Dryden; Basak E Dogan Journal: Curr Probl Diagn Radiol Date: 2015-04-27
Authors: Samantha L Heller; Ana P Lourenco; Bethany L Niell; Nicolas Ajkay; Ann Brown; Elizabeth H Dibble; Aarati D Didwania; Maxine S Jochelson; Katherine A Klein; Tejas S Mehta; Helen A Pass; Ashley R Stuckey; Mary E Swain; Daymen S Tuscano; Linda Moy Journal: J Am Coll Radiol Date: 2020-11 Impact factor: 5.532